David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Ezio Di Nucci
Jack Alan Reynolds
Learn more about PhilPapers
Developing World Bioethics 12 (1):35-44 (2012)
Stem cell tourism is a small but growing part of the thriving global medical tourism marketplace. Much stem cell research remains at the experimental stage, with clinical trials still uncommon. However, there are over 700 clinics estimated to be operating in mostly developing countries – from Costa Rica and Argentina to China, India and Russia – that have lured many patients, mostly from industrialized countries, driven by desperation and hope, which in turn continue to fuel the growth of such tourism.While much research has focused on such dimensions as the promotions that allow such businesses to make their services known, media coverage, some patient research, and regulatory conditions for developing country clinics, little attention has been paid to the non-affected members of the general population, the future potential users of such services. This empirical study based on five focus group discussions with a diverse group of healthy adults in a Canadian city, explored participant views of patients who use stem cell tourism services, the likelihood they would avail themselves of such services if they were to suffer similar illnesses, and the conditions under which they might do so, and the impact that admonitions and advice from international expert bodies might have on their decisions. Our findings suggest that these healthy adults are sympathetic to the drivers of hope and desperation, and, despite cautions about research limitations, may seek such treatments themselves under similar conditions. These findings are discussed in the context of the policy and ethical issues raised by this form of medical tourism
|Keywords||medical ethics medical tourism resource allocation developing world guidelines health priorities patient protection bioethics stem cell tourism stem cell regulation and public perceptions|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
Zubin Master, Amy Zarzeczny, Christen Rachul & Timothy Caulfield (2013). What's Missing? Discussing Stem Cell Translational Research in Educational Information on Stem Cell “Tourism”. Journal of Law, Medicine and Ethics 41 (1):254-268.
Similar books and articles
Aaron D. Levine & Leslie E. Wolf (2012). The Roles and Responsibilities of Physicians in Patients' Decisions About Unproven Stem Cell Therapies. Journal of Law, Medicine & Ethics 40 (1):122-134.
Cynthia B. Cohen Peter J. Cohen (2010). International Stem Cell Tourism and the Need for Effective Regulation: Part I: Stem Cell Tourism in Russia and India: Clinical Research, Innovative Treatment, or Unproven Hype? Kennedy Institute of Ethics Journal 20 (1):pp. 27-49.
Nikolaus Knoepffler (2004). Stem Cell Research: An Ethical Evaluation of Policy Options. Kennedy Institute of Ethics Journal 14 (1):55-74.
Cynthia B. Cohen Peter J. Cohen (2010). International Stem Cell Tourism and the Need for Effective Regulation: Part II: Developing Sound Oversight Measures and Effective Patient Support. Kennedy Institute of Ethics Journal 20 (3):207-230.
Haidan Chen & Herbert Gottweis (2013). Stem Cell Treatments in China: Rethinking the Patient Role in the Global Bio‐Economy. Bioethics 27 (4):194-207.
Insoo Hyun (2010). Allowing Innovative Stem Cell-Based Therapies Outside of Clinical Trials: Ethical and Policy Challenges. Journal of Law, Medicine & Ethics 38 (2):277-285.
David Magnus (2010). Translating Stem Cell Research: Challenges at the Research Frontier. Journal of Law, Medicine & Ethics 38 (2):267-276.
Tamra Lysaght & Alastair V. Campbell (2013). Broadening the Scope of Debates Around Stem Cell Research. Bioethics 27 (5):251-256.
Mark T. Brown (2009). Moral Complicity in Induced Pluripotent Stem Cell Research. Kennedy Institute of Ethics Journal 19 (1):pp. 1-22.
David Shaw (forthcoming). Hematopoietic Stem Cell Transplantation: Legal and Ethical Issues in the UK. In Jörg P. Halter Peter Bürkli (ed.), The Legal and Ethical Challenges of Present and Future Stem-Cell Transplantation. Schwabe Verlag
Shawn H. E. Harmon (2008). Emerging Technologies and Developing Countries: Stem Cell Research Regulation and Argentina. Developing World Bioethics 8 (2):138-150.
Bernard Dickens, International Society for Stem Cell Research (ISSCR) Guidelines for the Conduct of Human Embryonic Stem Cell Research (December 2006).
Rebecca Dresser (2010). Stem Cell Research as Innovation: Expanding the Ethical and Policy Conversation. Journal of Law, Medicine & Ethics 38 (2):332-341.
J. Snyder, V. A. Crooks & R. Johnston (2012). Perceptions of the Ethics of Medical Tourism: Comparing Patient and Academic Perspectives. Public Health Ethics 5 (1):38-46.
Zubin Master & G. K. D. Crozier (2012). The Ethics of Moral Compromise for Stem Cell Research Policy. Health Care Analysis 20 (1):50-65.
Added to index2012-03-17
Total downloads17 ( #203,283 of 1,789,824 )
Recent downloads (6 months)3 ( #262,646 of 1,789,824 )
How can I increase my downloads?